CAERUS MOLECULAR DIAGNOSTICS, INC.
LOS ALTOS, CA, 94024-6028
|# of Employees:||2|
|Socially and Economically Disadvantaged:||N|
DESCRIPTION provided by applicant Even as the cost and throughput of commercial sequencers has continued to improve over the last years there is still a need to further reduce sequencing costs ...SBIRPhase I2014Department of Health and Human Services
DESCRIPTION (provided by applicant): The feasibility of a label-free technology, Millikan Sequencing, will be evaluated for de novo sequencing of mammalian genomes for under 1,000. This novel seque ...SBIRPhase I2010Department of Health and Human Services